share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券

美股sec公告 ·  03/06 05:25
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares of the company, with an aggregate market value of $241,805.99, on 03/05/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Borgeson's compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 103,110 shares were sold for gross proceeds of $1,136,736.04.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares of the company, with an aggregate market value of $241,805.99, on 03/05/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Borgeson's compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 103,110 shares were sold for gross proceeds of $1,136,736.04.
Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年5月3日出售該公司20,054股A類股票，總市值爲241,805.99美元。這些股票最初於2016年1月9日作爲創始人的股份收購，是博格森從發行人那裏獲得的薪酬的一部分。這筆即將進行的交易是在過去三個月進行了一系列銷售之後進行的，共出售了103,110股股票，總收益爲1,136,736.04美元。
Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年5月3日出售該公司20,054股A類股票，總市值爲241,805.99美元。這些股票最初於2016年1月9日作爲創始人的股份收購，是博格森從發行人那裏獲得的薪酬的一部分。這筆即將進行的交易是在過去三個月進行了一系列銷售之後進行的，共出售了103,110股股票，總收益爲1,136,736.04美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。